Superficial Spreading Malignant Melanoma
2 clinical trials · Condition
◉ Watch Superficial Spreading Malignant Melanoma
| Record | Firm | Date |
|---|---|---|
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma (NCT01120275) | National Cancer Institute (NCI) | 2010-10-01 |
| AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma (NCT00243061) | National Cancer Institute (NCI) | 2006-01-01 |
Track Superficial Spreading Malignant Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.